Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

THE GENETICS OF CAENORHABDITIS ELEGANS

Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,220

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

A second generation human haplotype map of over 3.1 million SNPs

The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326

C. elegans : des neurones et des gènes

Gally, C., & Bessereau, J. (2003) · médecine/sciences · doi:10.1051/medsci/20031967725 · Cited by 3,260

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234

The molecular pathology of Alzheimer's disease

Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312

Establishment and Dysfunction of the Blood-Brain Barrier

Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670

Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis

Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357

Genetic architectures of psychiatric disorders: the emerging picture and its implications

Sullivan, P. F., Daly, M. J., & O'Donovan, M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3240 · Cited by 1,177

Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta

Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004

The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization

Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 892

Overview and Findings from the Rush Memory and Aging Project

Bennett, D. A., Schneider, J. A., Buchman, A. S., Barnes, L. L., Boyle, P. A., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322663 · Cited by 845

REST and stress resistance in ageing and Alzheimer’s disease

Lu, T., Aron, L., Zullo, J., Pan, Y., Kim, H., Chen, Y., Yang, T.-H., Kim, H., Drake, D., Liu, X., et al. (2014) · Nature · doi:10.1038/nature13163 · Cited by 784

Overview and Findings from the Religious Orders Study

Bennett, D. A., Schneider, J. A., Arvanitakis, Z., & Wilson, R. S. (2012) · Current Alzheimer Research · doi:10.2174/156720512801322573 · Cited by 653

The road to restoring neural circuits for the treatment of Alzheimer's disease

Canter, R. G., Penney, J., & Tsai, L.-H. (2016) · Nature · doi:10.1038/nature20412 · Cited by 565

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease

Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559

Identification and Rescue of α-Synuclein Toxicity in Parkinson Patient–Derived Neurons

Chung, C. Y., Khurana, V., Auluck, P. K., Tardiff, D. F., Mazzulli, J. R., Soldner, F., Baru, V., Lou, Y., Freyzon, Y., Cho, S., et al. (2013) · Science · doi:10.1126/science.1245296 · Cited by 454

Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance

Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410

Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

Kim, H., Raphael, A. R., LaDow, E., McGurk, L., Weber, R. A., Trojanowski, J. Q., Lee, V. M. ‐., Finkbeiner, S. M., Gitler, A. D., & Bonini, N. M. (2013) · Nature Genetics · doi:10.1038/ng.2853 · Cited by 383

Alzheimer's Disease and the Amyloid Cascade Hypothesis: A Critical Review

Reitz, C. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/369808 · Cited by 398

Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow

Xie, C., Zhuang, X., Niu, Z., Ai, R., Lautrup, S., Zheng, S., Jiang, Y., Han, R., Gupta, T. S., Cao, S., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00819-5 · Cited by 349

APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia

Sienski, G., Narayan, P., Bonner, J. M., Kory, N., Boland, S., Arczewska, A. A., Ralvenius, W. T., Akay, L., Lockshin, E., He, L., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4564 · Cited by 336

Genetic insights in Alzheimer's disease

Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70259-4 · Cited by 290

Genes associated with Alzheimer's disease: an overview and current status

Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311

Use of Caenorhabditis elegans as a model to study Alzheimer’s disease and other neurodegenerative diseases

Alexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310

A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ

Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M. D., Fak, J. J., Olsen, O., Darnell, R. B., & Tessier‐Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 324

The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease

Fernandez, C. G., Hamby, M. E., McReynolds, M. L., & Ray, W. J. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00014 · Cited by 277

APOBEC3A cytidine deaminase induces RNA editing in monocytes and macrophages

Sharma, S., Patnaik, S. K., Thomas Taggart, R., Kannisto, E. D., Enriquez, S. M., Gollnick, P., & Baysal, B. E. (2015) · Nature Communications · doi:10.1038/ncomms7881 · Cited by 264

Yeast Reveal a “Druggable” Rsp5/Nedd4 Network that Ameliorates α-Synuclein Toxicity in Neurons

Tardiff, D. F., Jui, N. T., Khurana, V., Tambe, M. A., Thompson, M. L., Chung, C. Y., Kamadurai, H., Kim, H. T., Lancaster, A. K., Caldwell, K. A., et al. (2013) · Science · doi:10.1126/science.1245321 · Cited by 250

CRISPR–Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity

Kramer, N. J., Haney, M. S., Morgens, D. W., Jovičić, A., Couthouis, J., Li, A., Ousey, J., Ma, R., Bieri, G., Tsui, C. K., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0070-7 · Cited by 226

Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors

Van Acker, Z. P., Bretou, M., & Annaert, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0323-7 · Cited by 222

Cell Culture Media: A Review

Arora, M. (2013) · Materials and Methods · doi:10.13070/mm.en.3.175 · Cited by 247

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies

Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212

HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework

Varol, E., Sotiras, A., & Davatzikos, C. A. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.041 · Cited by 217

Genetics of Alzheimer’s Disease

Chouraki, V. A., & Seshadri, S. S. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800149-3.00005-6 · Cited by 220

Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities

Singh, N., Haldar, S., Tripathi, A. K., Horback, K., Wong, J., Sharma, D., Beserra, A., Suda, S., Anbalagan, C., Dev, S., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4931 · Cited by 208

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1

Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205

Amyloid-β Peptide Induces Mitochondrial Dysfunction by Inhibition of Preprotein Maturation

Mossmann, D., Vögtle, F. ‐., Taşkin, A. A., Teixeira, P. F., Ring, J., Burkhart, J. M., Burger, N., Pinho, C. M., Tadić, J., Loreth, D., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.024 · Cited by 196

The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM

Miller, S. E., Sahlender, D. A., Graham, S. C., Höning, S., Robinson, M. S., Peden, A. A., & Owen, D. J. (2011) · Cell · doi:10.1016/j.cell.2011.10.038 · Cited by 192

Bridging integrator 1 (BIN1): form, function, and Alzheimer's disease

Tan, M., Yu, J., & Tan, L. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.004 · Cited by 201

Membrane Trafficking Pathways in Alzheimer's Disease

Rajendran, L., & Annaert, W. (2012) · Traffic · doi:10.1111/j.1600-0854.2012.01332.x · Cited by 171

Endosomal traffic jams represent a pathogenic hub and therapeutic target in Alzheimer’s disease

Small, S. A., Simoes-Spassov, S., Mayeux, R., & Petsko, G. A. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.08.003 · Cited by 168

Clioquinol promotes the degradation of metal-dependent amyloid-β (Aβ) oligomers to restore endocytosis and ameliorate Aβ toxicity

Matlack, K. E. S., Tardiff, D. F., Narayan, P. S., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., & Lindquist, S. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402228111 · Cited by 166

Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis

Xiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338376 · Cited by 166

Early etiology of Alzheimer’s disease: tipping the balance toward autophagy or endosomal dysfunction?

Peric, A., & Annaert, W. G. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1379-7 · Cited by 172

Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology

Shulman, J. M., Chen, K., Keenan, B. T., Chibnik, L. B., Fleisher, A., Thiyyagura, P., Roontiva, A., Aubin, C., Patsopoulos, N. A., Corneveaux, J. J., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.2815 · Cited by 162

Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer’s disease pathogenesis

Zhu, L., Zhong, M., Elder, G. A., Sano, M., Holtzman, D. M., Gandy, S., Cardozo, C., Haroutunian, V., Robakis, N. K., & Cai, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510011112 · Cited by 160

Modeling neurodegeneration in Caenorhabditis elegans

Caldwell, K. A., Willicott, C. W., & Caldwell, G. A. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.046110 · Cited by 165

Enteroviruses Harness the Cellular Endocytic Machinery to Remodel the Host Cell Cholesterol Landscape for Effective Viral Replication

Ilnytska, O., Santiana, M., Hsu, N.-Y., Du, W., Chen, Y.-H., Viktorova, E. G., Belov, G. A., Brinker, A., Storch, J., Moore, C., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.08.002 · Cited by 156

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways

Rosenthal, S. L., & Kamboh, M. I. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0034-x · Cited by 162

Caenorhabditis elegans as a model system for human diseases

Markaki, M., & Tavernarakis, N. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.12.011 · Cited by 165

Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood

Lunnon, K., Ibrahim, Z. M., Proitsi, P., Lourdusamy, A., Newhouse, S., Sattlecker, M., Furney, S. J., Saleem, M., Soininen, H. S., Kłoszewska, I., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111592 · Cited by 145

Profilin 1 Associates with Stress Granules and ALS-Linked Mutations Alter Stress Granule Dynamics

Figley, M. D., Bieri, G., Kolaitis, R., Taylor, J. P., & Gitler, A. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0543-14.2014 · Cited by 139

Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain

Scheckel, C., Drapeau, E., Frias, M. A., Park, C. Y., Fak, J., Zucker-Scharff, I., Kou, Y., Haroutunian, V., Ma'ayan, A., Buxbaum, J. D., et al. (2016) · eLife · doi:10.7554/elife.10421 · Cited by 139

Efficient protein production by yeast requires global tuning of metabolism

Huang, M., Bao, J., Hallström, B. M., Petranović, D., & Nielsen, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00999-2 · Cited by 142

Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains

Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1111-z · Cited by 136

Inhibiting Stearoyl-CoA Desaturase Ameliorates α-Synuclein Cytotoxicity

Vincent, B. M., Tardiff, D. F., Piotrowski, J. S., Aron, R., Lucas, M. C., Chung, C. Y., Bacherman, H., Chen, Y., Pires, M., Subramaniam, R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.028 · Cited by 133

Conserved features of intermediates in amyloid assembly determine their benign or toxic states

Krishnan, R., Goodman, J. L., Mukhopadhyay, S., Pacheco, C. D., Lemke, E. A., Deniz, A. A., & Lindquist, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209527109 · Cited by 131

The Role of PICALM in Alzheimer’s Disease

Xu, W., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8878-3 · Cited by 124

Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways

Khurana, V., Peng, J., Chung, C. Y., Auluck, P. K., Fanning, S., Tardiff, D. F., Bartels, T., Koeva, M., Eichhorn, S. W., Benyamini, H., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2016.12.011 · Cited by 121

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

Lublin, A. L., & Link, C. D. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.02.002 · Cited by 119

Modeling neurodegenerative diseases in Caenorhabditis elegans

Li, J., & Le, W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.09.024 · Cited by 125

Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer’s disease

Marcello, E. E., Saraceno, C., Musardo, S., Vara, H., de la Fuente, A. G., Pelucchi, S., Marino, D. D., Borroni, B., Tramontano, A. L., Pérez‐Otaño, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65401 · Cited by 120

Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases

Chen, X., Barclay, J. W., Burgoyne, R. D., & Morgan, A. (2015) · Chemistry Central Journal · doi:10.1186/s13065-015-0143-y · Cited by 116

Defective Transcytosis of APP and Lipoproteins in Human iPSC-Derived Neurons with Familial Alzheimer’s Disease Mutations

Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.034 · Cited by 105

pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers

Tipping, K. W., Karamanos, T. K., Jakhria, T., Iadanza, M. G., Goodchild, S. C., Tůma, R., Ranson, N. A., Hewitt, E. W., & Radford, S. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423174112 · Cited by 113

Amyloid-β(1–42) Aggregation Initiates Its Cellular Uptake and Cytotoxicity

Jin, S., Kedia, N., Illes‐Toth, E., Haralampiev, I., Prisner, S., Herrmann, A., Wanker, E. E., & Bieschke, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691840 · Cited by 109

Role of genes linked to sporadic Alzheimer’s disease risk in the production of β-amyloid peptides

Bali, J., Gheinani, A. H., Zurbriggen, S., & Rajendran, L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201632109 · Cited by 107

PICALM and Alzheimer’s Disease: An Update and Perspectives

Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104

Efforts to make and apply humanized yeast

Laurent, J. M., Young, J. H., Kachroo, A. H., & Marcotte, E. M. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv041 · Cited by 99

The purinosome, a multi-protein complex involved in the de novo biosynthesis of purines in humans

Zhao, H., French, J. B., Ye, F., & Benkovic, S. J. (2013) · Chemical Communications · doi:10.1039/c3cc41437j · Cited by 105

Trisomy for Synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes

Cossec, J., Lavaur, J., Berman, D. E., Rivals, I., Hoischen, A., Stora, S., Ripoll, C., Mircher, C., Grattau, Y., Olivo‐Marín, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds142 · Cited by 106

Slow Excitotoxicity in Alzheimer's Disease

Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 106

Rationally Designed Peptidomimetic Modulators of Aβ Toxicity in Alzheimer's Disease

Rajasekhar, K., Suresh, S., Manjithaya, R. R., & Govindaraju, T. (2015) · Scientific Reports · doi:10.1038/srep08139 · Cited by 95

Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease

Kundra, R., Ciryam, P., Morimoto, R. I., Dobson, C. M., & Vendruscolo, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618417114 · Cited by 93

Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase

Kanatsu, K., Morohashi, Y., Suzuki, M., Kuroda, H., Watanabe, T., Tomita, T., & Iwatsubo, T. (2014) · Nature Communications · doi:10.1038/ncomms4386 · Cited by 99

Harnessing the power of yeast to unravel the molecular basis of neurodegeneration

Tenreiro, S., Munder, M. C., Alberti, S., & Outeiro, T. F. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12271 · Cited by 88

Oxidative Stress in Alzheimer's and Parkinson's Diseases: Insights from the YeastSaccharomyces cerevisiae

Pimentel, C., Batista-Nascimento, L. S., Rodrigues‐Pousada, C., & Menezes, R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/132146 · Cited by 86

Amyloid-β Induces Hepatic Insulin Resistance In Vivo via JAK2

Zhang, Y., Zhou, B. Z., Deng, B., Zhang, F., Wu, J., Wang, Y., Le, Y., & Zhai, Q. (2012) · Diabetes · doi:10.2337/db12-0670 · Cited by 85

Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis

Cao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 82

Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders

Roussos, A., Kitopoulou, K., Borbolis, F., & Palikaras, K. (2023) · Biomolecules · doi:10.3390/biom13030478 · Cited by 82

PICALM Rescues Endocytic Defects Caused by the Alzheimer’s Disease Risk Factor APOE4

Narayan, P., Sienski, G., Bonner, J. M., Lin, Y.-T., Seo, J., Baru, V., Haque, A., Milo, B., Akay, L. A., Graziosi, A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108224 · Cited by 75

Reduction of Synaptojanin 1 Ameliorates Synaptic and Behavioral Impairments in a Mouse Model of Alzheimer's Disease

McIntire, L. B., Berman, D. E., Myaeng, J., Staniszewski, A., Arancio, O., Paolo, G. D., & Kim, T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2034-12.2012 · Cited by 78

A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity

D’Angelo, F., Vignaud, H., Martino, J. S. D., Salin, B., Devin, A., Cullin, C., & Marchal, C. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010108 · Cited by 80

The N-Terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH through a Gain of Function Mechanism

Brännström, K., Öhman, A., Nilsson, L., Pihl, M., Sandblad, L., & Olofsson, A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503535m · Cited by 74

FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism

Chen, X., Ji, B., Hao, X., Li, X., Eisele, F., Nyström, T., & Petranović, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14525-4 · Cited by 77

Toward stem cell-based phenotypic screens for neurodegenerative diseases

Khurana, V., Tardiff, D. F., Chung, C. Y., & Lindquist, S. L. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.79 · Cited by 72

The multifactorial nature of healthy brain ageing: Brain changes, functional decline and protective factors

Turrini, S., Wong, B., Eldaief, M. C., Press, D. Z., Sinclair, D. A., Koch, G., Avenanti, A., & Santarnecchi, E. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101939 · Cited by 88

Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta

Teo, E., Ravi, S., Barardo, D., Kim, H.-S., Fong, S., Cazenave-Gassiot, A., Tan, T. Y., Ching, J., Kovalik, J.-P., Wenk, M. R., et al. (2019) · eLife · doi:10.7554/elife.50069 · Cited by 72

Dynamic interplay between cell membrane tension and clathrin‐mediated endocytosis

Djakbarova, U., Madraki, Y., Chan, E. T., & Kural, C. (2021) · Biology of the Cell · doi:10.1111/boc.202000110 · Cited by 66

Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective

Talwar, P., Sinha, J., Grover, S., Rawat, C., Kushwaha, S. S., Agarwal, R., Taneja, V., & Kukreti, R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9390-0 · Cited by 71

Latrepirdine (Dimebon™) Enhances Autophagy and Reduces Intracellular GFP-Aβ42 Levels in Yeast

Bharadwaj, P. R., Verdile, G., Barr, R. K., Gupta, V. B., Steele, J., Lachenmayer, M. L., Yue, Z., Ehrlich, M. E., Petsko, G. A., Ju, S., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120178 · Cited by 69

Approaches to study yeast cell aging and death

Mirisola, M. G., Braun, R. J., & Petranović, D. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12112 · Cited by 72

Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation

Bar‐Yosef, D. L., Sade, D., Shaham‐Niv, S., Zaguri, D., Gartner, M., Basavalingappa, V., Raveh, A., Pichinuk, E., Engel, H., Iwasaki, K., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07966-5 · Cited by 67

The Molecular Pathology of Alzheimer's Disease

Harrington, C. R. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.003 · Cited by 70

The PICALM Protein Plays a Key Role in Iron Homeostasis and Cell Proliferation

Scotland, P., Heath, J. L., Conway, A. E., Porter, N. B., Armstrong, M. B., Walker, J. A., Klebig, M. L., Lavau, C., & Wechsler, D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044252 · Cited by 67

ATP5H/KCTD2 locus is associated with Alzheimer's disease risk

Initiative, A. D. N., Boada, M., Antúnez, C., Ramírez‐Lorca, R., DeStefano, A. L., González‐Pérez, A., Gayán, J., López‐Arrieta, J., Ikram, M. A., Hernández, I., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.86 · Cited by 65

Genetic and Pharmacological Discovery for Alzheimer’s Disease Using Caenorhabditis elegans

Griffin, E. F., Caldwell, K. A., & Caldwell, G. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00361 · Cited by 70

Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases

Sin, O., Michels, H., & Nollen, E. A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.015 · Cited by 72

The Involvement of Lipids in Alzheimer's Disease

Lim, W. L. F., Martins, I. J., & Martins, R. N. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.04.003 · Cited by 67

Fluorescent dye ProteoStat to detect and discriminate intracellular amyloid‐like aggregates in Escherichia coli

Navarro, S., & Ventura, S. (2014) · Biotechnology Journal · doi:10.1002/biot.201400291 · Cited by 64

Oxidative stress and aging: Learning from yeast lessons

Eleuthério, E. C. A., Brasil, A. D. A., França, M. B., de Almeida, D. S. G., Rona, G. B., & Magalhães, R. S. S. (2017) · Fungal Biology · doi:10.1016/j.funbio.2017.12.003 · Cited by 64

Caenorhabditis elegans as a model system for studying non-cell-autonomous mechanisms in protein-misfolding diseases

Nussbaum-Krammer, C. I., & Morimoto, R. I. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013011 · Cited by 68

PIPs in neurological diseases

Waugh, M. G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.002 · Cited by 59

Functional links between Ab toxicity, endocytic trafficking, and Alzheimer’s disease risk factors in yeast. Science 334

Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2011)

Functional Links Between Ab Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast

Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2016)

If yeast had brains

Chen, I. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2201

PERSPECTIVES

(2011)

A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicity

D’Angelo, F., Vignaud, H., Martino, J. S. D., Salin, B., Devin, A., Cullin, C., & Marchal, C. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010108 · Cited by 80